Senate Will Tackle Separate Device Reform Bills As Part Of Innovation Agenda
This article was originally published in The Gray Sheet
Multiple bills focused on accelerating the path to market for devices will join safety legislation reforming the regulation of duodenoscopes in a slate of Senate bills that HELP Committee Chairman Lamar Alexander said will receive hearings in February, March and April. The legislation-by-legislation approach in the Senate differs from the broad-based 21st Century Cures package that advanced in the House.
You may also be interested in...
Party Leaders, Former St. Jude Exec Lead In Medtech Campaign Donations
For the 2015-2016 congressional campaign election cycle, House and Senate party leaders, as well as incumbents sponsoring industry-supported bills, are attracting significant donations. But one of industry's own, former St Jude Medical employee Angie Craig, is making a run as a Democrat for a House seat in Minnesota's 2nd congressional district. She has received the most donations from industry, in particular from her former St Jude colleagues, campaign funding data compiled by The Gray Sheet shows.
Senate Panel Passes Breakthrough Device, Other Measures; FDA Funding Debated
The Senate HELP Committee voted March 9 in favor of a breakthrough device provision, watered down from a version approved in the House last year. Other bills voted out of committee include a combination products reform measure, the digital-health focused MEDTECH Act, and four others. Senators are still debating whether NIH and FDA should get additional funds to cover the cost of the bills, which will be wrapped up into a broader package before Senate floor debate.
Next AdvaMed Chief Is BIO Exec Scott Whitaker
Whitaker, appointed as the next CEO of AdvaMed, currently runs day-to-day operations at the Biotechnology Innovation Organization and has held high-level posts at HHS. Among his accomplishments, Whitaker led the legislative office at HHS when the first device user fee bill was passed in 2002.